WMSA
UTHR icon

Weiss Multi-Strategy Advisers’s United Therapeutics UTHR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$2.64M – 456
2023
Q4 		$2.64M Buy
12,000
+6,834
+132% +$1.58M 0.06% 336
2023
Q3 		$1.17M Buy
5,166
+473
+10% +$109K 0.03% 423
2023
Q2 		$1.04M Buy
4,693
+1,745
+59% +$387K 0.02% 536
2023
Q1 		$660K Sell
2,948
-52
-2% -$12.8K 0.02% 536
2022
Q4 		$834K Sell
3,000
-2,000
-40% -$505K 0.02% 477
2022
Q3 		$1.05M Sell
5,000
-1,500
-23% -$335K 0.03% 488
2022
Q2 		$1.53M Sell
6,500
-8,110
-56% -$1.65M 0.05% 433
2022
Q1 		$2.62M Sell
14,610
-3,929
-21% -$749K 0.06% 358
2021
Q4 		$4.01M Sell
18,539
-211
-1% -$41.4K 0.09% 282
2021
Q3 		$3.46M Buy
18,750
+1,750
+10% +$345K 0.07% 318
2021
Q2 		$3.05M Sell
17,000
-1,081
-6% -$206K 0.07% 348
2021
Q1 		$3.02M Sell
18,081
-480
-3% -$80K 0.07% 345
2020
Q4 		$2.82M Sell
18,561
-4,688
-20% -$615K 0.05% 356
2020
Q3 		$2.35M Buy
23,249
+3,749
+19% +$411K 0.06% 327
2020
Q2 		$2.36M Buy
19,500
+2,672
+16% +$301K 0.07% 308
2020
Q1 		$1.6M Buy
+16,828
New +$1.6M 0.06% 265
2014
Q2 		– Sell
-4,690
Closed -$441K – 931
2014
Q1 		$441K Buy
4,690
+600
+15% +$61.4K 0.01% 698
2013
Q4 		$462K Buy
4,090
+550
+16% +$49.6K 0.01% 653
2013
Q3 		$279K Buy
+3,540
New +$259K 0.01% 668

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's UTHR Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 12,000 shares — an estimated $2.64M sold.

Weiss Multi-Strategy Advisers first reported a position in UTHR in Q3 2013 and held it in 19 quarters. The position peaked at $4.01M in Q4 2021. 525 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,000 United Therapeutics shares in Q1 2024, an estimated $2.64M.
  • Weiss Multi-Strategy Advisers first reported a position in United Therapeutics in Q3 2013 and held it in 19 quarters.
  • Weiss Multi-Strategy Advisers's United Therapeutics position peaked at $4.01M in Q4 2021.
  • 525 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.